v3.25.2
Investments
6 Months Ended
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Investments

5. Investments

 

Available-for-sale Investments

The following tables summarize the composition of our short- and long-term investments at June 30, 2025 and December 31, 2024.

 

 

June 30, 2025

 

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Aggregate
Fair Value

 

 

 

(in thousands)

 

Commercial paper

 

$

3,715

 

 

$

 

 

$

 

 

$

3,715

 

Corporate bonds

 

 

286,512

 

 

 

773

 

 

 

(70

)

 

 

287,215

 

U.S. Government agency securities

 

 

93,019

 

 

 

97

 

 

 

(36

)

 

 

93,080

 

U.S. Treasury securities

 

 

875,704

 

 

 

27

 

 

 

(155

)

 

 

875,576

 

Total

 

$

1,258,950

 

 

$

897

 

 

$

(261

)

 

$

1,259,586

 

 

 

 

December 31, 2024

 

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Aggregate
Fair Value

 

 

 

(in thousands)

 

Commercial paper

 

$

4,941

 

 

$

 

 

$

 

 

$

4,941

 

Corporate bonds

 

 

284,337

 

 

 

533

 

 

 

(295

)

 

 

284,575

 

U.S. Government agency securities

 

 

117,158

 

 

 

260

 

 

 

(49

)

 

 

117,369

 

U.S. Treasury securities

 

 

1,303,384

 

 

 

780

 

 

 

(9

)

 

 

1,304,155

 

Total

 

$

1,709,820

 

 

$

1,573

 

 

$

(353

)

 

$

1,711,040

 

For available-for-sale debt securities, any realized gains and losses are determined based on the specific identification method and are reported in other income (expense) in the consolidated statements of operations. For securities in an unrealized loss position, the Company first assesses whether it intends to sell or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense) in the consolidated statements of operations. It is noted that the Company does not intend to sell these investments and it is more likely than not that the Company will not be required to sell these investments before recovery of their amortized cost basis.

If neither of the above criteria is met, the Company further assesses whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, credit ratings, the financial health of the industry and sector of the issuer, the overall risk profile of the securities, overall macroeconomic conditions, and more. Any credit-related unrealized losses are recognized as an allowance on the consolidated balance sheets with a corresponding charge in other income (expense) in the consolidated statements of operations. Non-credit related unrealized losses and unrealized gains on available-for-sale debt securities are included in accumulated other comprehensive income (loss). In considering the underlying risk of its portfolio, the Company notes that it has a zero-loss expectation for U.S. treasury and U.S. government agency securities, which represents the majority of its debt investment available-for-sale securities portfolio. As of June 30, 2025 and December 31 2024, no allowance for credit losses in investments was recorded.

The contractual maturities of short-term and long-term investments held at June 30, 2025 and December 31, 2024 are as follows:

 

 

June 30, 2025

 

 

December 31, 2024

 

 

 

Amortized
Cost Basis

 

 

Aggregate
Fair Value

 

 

Amortized
Cost Basis

 

 

Aggregate
Fair Value

 

 

 

(in thousands)

 

 

(in thousands)

 

Due within one year

 

$

1,068,090

 

 

$

1,068,335

 

 

$

1,555,656

 

 

$

1,556,828

 

Due after 1 year through 2 years

 

 

190,860

 

 

 

191,251

 

 

 

154,164

 

 

 

154,212

 

Total

 

$

1,258,950

 

 

$

1,259,586

 

 

$

1,709,820

 

 

$

1,711,040

 

 

 

Strategic Investments

The Company holds strategic investments in non-marketable equity securities of privately held companies. These investments are included in other assets on the consolidated balance sheets.

Strategic investments that consist of non-controlling equity investments without readily determinable fair values in privately held companies for which the Company does not have the ability to exercise significant influence are measured under the measurement alternative method. Under the measurement alternative method of accounting, the non-marketable equity securities are carried at cost less any impairment, plus or minus adjustments resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Any associated gains and losses are recorded in other income (expense) in the consolidated statement of operations. The Company has certain other non-marketable strategic investments that do not qualify for the measurement alternative method. These investments are measured at fair value with any gains and losses recorded in other income (expense) in the consolidated statement of operations.

Strategic investments that consist of non-controlling equity investments without readily determinable fair values, in which the Company has significant influence over the investee’s operating and financial policies are accounted for under the equity method of accounting. Under the equity method of accounting, the Company's proportionate share of the investments' net earnings are recorded in other income (expense) in the consolidated statements of operations and the related increase or decrease to the investment balance is recorded on the consolidated balance sheets.

The carrying values of Company’s strategic investments broken down by categories mentioned above are as follows:
 

 

 

June 30, 2025

 

 

December 31, 2024

 

 

 

(in thousands)

 

Measurement alternative method

 

$

84,237

 

 

$

72,456

 

Fair value

 

 

15,842

 

 

 

9,409

 

Equity method

 

 

12,558

 

 

 

11,678

 

Total

 

$

112,637

 

 

$

93,543

 

The following table summarizes the activity associated with the Company’s strategic investments, which is reported on the Company’s consolidated statement of operations as other income (expense):
 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

(in thousands)

 

 

(in thousands)

 

Strategic investments:

 

 

 

 

 

 

 

 

 

 

 

 

Gains

 

$

1,754

 

 

$

2,103

 

 

$

1,869

 

 

$

18,456

 

Impairments

 

 

 

 

 

(479

)

 

 

(1,600

)

 

 

(4,094

)

Total included in other income

 

$

1,754

 

 

$

1,624

 

 

$

269

 

 

$

14,362